AR044123A1 - Composicion de acido rosmarinico - Google Patents
Composicion de acido rosmarinicoInfo
- Publication number
- AR044123A1 AR044123A1 ARP040101451A ARP040101451A AR044123A1 AR 044123 A1 AR044123 A1 AR 044123A1 AR P040101451 A ARP040101451 A AR P040101451A AR P040101451 A ARP040101451 A AR P040101451A AR 044123 A1 AR044123 A1 AR 044123A1
- Authority
- AR
- Argentina
- Prior art keywords
- rosmarinic acid
- weight
- ginsenoside
- acid composition
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Métodos y composiciones que comprenden ácido rosmarínico. Composiciones que comprenden borneol, ácido rosmarínico y al menos un ginsenosida. Reivindicación 21: El preparado de la reivindicación 16, en donde al menos un ginsenosida comprende la menos un ginsenosida Rb1 y ginsenosida Rg1. Reivindicación 36: Una pastilla de rápida disolución que comprende, entre aproximadamente 18 % a aproximadamente 60 % por peso del polvo de la reivindicación 30; entre aproximadamente 30 % a aproximadamente 80 % por peso de un diluyente soluble en agua; entre aproximadamente 5 % a aproximadamente 15 % por poso de un aglutinante; y entre aproximadamente 3 % a aproximadamente 40 % por peso de un endulzante, con los porcentajes siendo por peso y totalizando el 100 %.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/407,685 US20040202730A1 (en) | 2003-04-08 | 2003-04-08 | Rosmarinic acid composition |
US10/818,010 US20040202731A1 (en) | 2003-04-08 | 2004-04-05 | Rosmarinic acid composition |
Publications (1)
Publication Number | Publication Date |
---|---|
AR044123A1 true AR044123A1 (es) | 2005-08-24 |
Family
ID=33302755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040101451A AR044123A1 (es) | 2003-04-08 | 2004-04-28 | Composicion de acido rosmarinico |
Country Status (3)
Country | Link |
---|---|
US (1) | US20040202731A1 (es) |
AR (1) | AR044123A1 (es) |
WO (1) | WO2004091645A2 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100740609B1 (ko) * | 2004-06-11 | 2007-07-18 | 주식회사 유니젠 | 진세노사이드를 포함하는 혈관 협착 및 재협착 예방 또는치료용 조성물 |
ITMI20041871A1 (it) * | 2004-10-01 | 2005-01-01 | Indena Spa | Uso di santoreggia satureja montana o dei suoi estratti per la preparazione di medicamenti per il trattamento dell'eiaculazione precoce |
KR100750988B1 (ko) | 2005-03-18 | 2007-08-22 | 주식회사 유니젠 | 천연물유래 진세노사이드를 포함하는 당뇨 또는혈당조절이상의 예방 또는 치료용 약학 조성물 |
GB0623618D0 (en) * | 2006-11-27 | 2007-01-03 | Mars Uk Ltd | Composition |
WO2008090474A2 (en) * | 2007-01-24 | 2008-07-31 | University Of Guelph | Production of rosmarinic acid from spearmint and uses thereof |
MX2010009015A (es) * | 2008-02-19 | 2010-11-26 | Unigen Inc | Extracto de hojas de especie panax, proceso para hacer el mismo y usos del mismo. |
CN101574359B (zh) * | 2008-05-09 | 2011-09-14 | 昆明制药集团股份有限公司 | 一种治疗心脑血管疾病的药物组合物 |
FR2951085B1 (fr) * | 2009-10-09 | 2012-05-18 | Inst Substances Vegetales | Utilisation de composes phenoliques pour la deglycation des proteines |
US9283243B2 (en) | 2010-06-01 | 2016-03-15 | Cornell University Cornell Center For Technology, Enterprise & Commercialization (“Cctec”) | CD36 inhibition to control obesity and insulin sensitivity |
FR3007980B1 (fr) * | 2013-07-05 | 2015-07-24 | Clarins Lab | Utilisation cosmetique d un extrait de sanicula europaea |
CN104435493B (zh) * | 2013-11-22 | 2018-06-08 | 钟毓原 | 养生液 |
CN104306584A (zh) * | 2014-11-04 | 2015-01-28 | 王慧 | 治疗风湿性心脏病合并尿少浮肿的制剂及制备方法 |
CN104352658A (zh) * | 2014-11-04 | 2015-02-18 | 王慧 | 气滞血瘀型风湿性心脏病活血制剂及制备方法 |
CN104306565A (zh) * | 2014-11-04 | 2015-01-28 | 王慧 | 治疗气滞血瘀型心绞痛的中药制剂及制备方法 |
CN104435088A (zh) * | 2014-11-07 | 2015-03-25 | 都匀市基佑生物科技有限公司 | 一种治疗高血压的中草药粉剂 |
CN104435080A (zh) * | 2014-11-10 | 2015-03-25 | 成都果睿医药科技有限公司 | 一种含有人参的治疗心脑血管疾病的药物组合物 |
CN104367630A (zh) * | 2014-11-10 | 2015-02-25 | 成都果睿医药科技有限公司 | 一种含有西洋参的治疗心脑血管疾病的药物组合物 |
CN104435074A (zh) * | 2014-11-10 | 2015-03-25 | 成都果睿医药科技有限公司 | 一种含有红景天的治疗心脑血管疾病的药物组合物 |
CN104367725A (zh) * | 2014-11-10 | 2015-02-25 | 成都果睿医药科技有限公司 | 一种含有灯盏细辛的治疗心脑血管疾病的药物组合物 |
CN104435107A (zh) * | 2014-11-10 | 2015-03-25 | 成都果睿医药科技有限公司 | 一种含有川芎的治疗心脑血管疾病的药物组合物 |
CN104435106A (zh) * | 2014-11-10 | 2015-03-25 | 成都果睿医药科技有限公司 | 一种含有丹参的治疗心脑血管疾病的药物组合物 |
CN104367618A (zh) * | 2014-11-10 | 2015-02-25 | 成都果睿医药科技有限公司 | 一种含有广枣的治疗心脑血管疾病的药物组合物 |
CN109295080B (zh) * | 2018-09-19 | 2021-08-20 | 昆明理工大学 | 珠子参β-香树脂醇合成酶基因Pjβ-AS的用途 |
CN111876447B (zh) * | 2019-06-25 | 2022-04-01 | 陕西鸿道生物分析科学技术研究院有限公司 | 一种生产迷迭香酸的菌株及方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2556969B1 (fr) * | 1983-12-27 | 1986-04-25 | Oreal | Composition cosmetique ou pharmaceutique a base d'extraits vegetaux ayant une action sur la fragilite capillaire |
JPH04316448A (ja) * | 1991-04-12 | 1992-11-06 | Iwatani Internatl Corp | 人参微粉末の製造方法 |
JPH09255526A (ja) * | 1996-03-27 | 1997-09-30 | Shiseido Co Ltd | 老化防止化粧料 |
US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
US6083932A (en) * | 1997-04-18 | 2000-07-04 | Cv Technologies Inc. | Pharmaceutical compositions derived from ginseng and methods of treatment using same |
US20020155177A1 (en) * | 2000-09-29 | 2002-10-24 | Krasutsky Pavel A. | Process for extracting compounds from plants |
EP1351698B1 (en) * | 2000-12-22 | 2013-01-23 | Tasly Pharmaceutical Group Co., Ltd. | Herbal composition for angina pectoris, method to prepare same and uses thereof |
US8486464B2 (en) * | 2000-12-22 | 2013-07-16 | Tasly Pharmaceutical Group Co. Ltd. | Herbal composition for angina pectoris, method to prepare same and uses thereof |
-
2004
- 2004-04-05 US US10/818,010 patent/US20040202731A1/en not_active Abandoned
- 2004-04-08 WO PCT/US2004/010830 patent/WO2004091645A2/en active Application Filing
- 2004-04-28 AR ARP040101451A patent/AR044123A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2004091645A2 (en) | 2004-10-28 |
US20040202731A1 (en) | 2004-10-14 |
WO2004091645A3 (en) | 2004-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR044123A1 (es) | Composicion de acido rosmarinico | |
AR056055A1 (es) | Complejos cristalinos e hidratos de 1-cloro-4-(beta-d-glucopiranos-1-il)-2-(4-etinil-bencil)-benceno | |
AR083480A1 (es) | Mezclas de stevia que contienen rebaudiosida b | |
CO6400186A2 (es) | Tabletas de acetato de ulipristal | |
AR072261A1 (es) | Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos. | |
TNSN07360A1 (en) | Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof | |
AR084215A1 (es) | Bifidobacterium cect 7765 y su uso en la prevencion y/o tratamiento del sobrepeso, la obesidad y patologias asociadas | |
PE20061107A1 (es) | Composiciones de tigeciclina y metodos para su preparacion | |
AR084663A1 (es) | Preparados liofilizados de inhibidores de proteasomas | |
AR054525A1 (es) | Composiciones y metodos para eltratamiento de sintomas relacionados con el ciclo | |
CU23850B1 (es) | Composiciones farmacéuticas estabilizadas que comprenden fesoterodina | |
CR11418A (es) | Trans-clomifeno para el sindrome metabolico | |
BRPI0818541B8 (pt) | composição farmacêutica que compreende grânulos incluindo picossulfato de sódio e bicarbonato de potássio e seu processo para a preparação | |
WO2004017998A3 (en) | Topical emulsion- gel composition comprising diclofenac sodium | |
AR079639A1 (es) | Composicion de pasta de dientes anti-erosiva | |
TW200501965A (en) | Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle | |
AR091039A1 (es) | Composiciones farmaceuticas topicas que comprenden terbinafina, uso y metodo de tratamiento | |
AR089269A1 (es) | Composiciones para el cuidado oral | |
AR053678A1 (es) | Compuestos farmaceuticamente activos, su manufactura, composiciones que los contienen y su uso | |
UA107487C2 (uk) | Склад для профілактики кандидозів | |
ECSP10010078A (es) | Co-cristales de pirimetanilo y ditianona | |
CO6541623A2 (es) | Soluciones de rehidratación oral que comprende dextrosa | |
TW200833371A (en) | Process for solid formulations | |
AR046769A1 (es) | Composiciones farmaceuticas | |
MX2010003594A (es) | Formas cristalinas de sal sodica de dmxaa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |